Skip to content

The Study of the Mechanisms of Increased Vulnerability to Myocardial Ischemia-Reperfusion Injury in Diabetic Patients

The Study of the Mechanisms of Increased Vulnerability to Myocardial Ischemia-Reperfusion Injury in Diabetic Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-BOC-17013529
Enrollment
Unknown
Registered
2017-11-24
Start date
2017-12-01
Completion date
Unknown
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic myocardial ischemia reperfusion injury

Interventions

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. diagnosed as rheumatic heart disease, coronary heart disease or congenital heart disease, heart valve replacement surgery, congenital heart disease septal repair, CBP coronary artery bypass grafting (CABG) and required open-chest surgery in patients undergoing cardiopulmonary bypass; 2. younger than 70 years old; 3. ASA classification II-III level; 4. Diabetes Mellitus (Definite Diabetes Diagnosis and Treatment).

Exclusion criteria

Exclusion criteria: 1. serious liver and kidney dysfunction; 2. combined infection; 3. combined tumor; 4. pregnancy, lactating women; 5. with hypertension or pulmonary heart disease; 6. acute heart failure patients; 7. emergency surgery; 8. malignant arrhythmia.

Design outcomes

Primary

MeasureTime frame
PTEN, p-PTEN, DJ-1, Setrin2, NLRP3, caspase-1, LC3II/I, P62, Beclin-1, Caspase-3, Bcl-2, NCoR1, HDAC3, Rev-erba, BMAL1, C/EBPß, Atg4b;SOD, MDA, 15-F2t, ROS, IL-18, TNFa;The time of postoperative mechanical ventilation, ICU treatment and hospital stay, and the rate of postoperative complications;

Secondary

MeasureTime frame
Blood Troponin T;CK-MB;

Countries

China

Contacts

Public ContactZhong-yuan Xia

Department of Anesthesiology, Renmin Hospital of Wuhan University

xiazhongyuan2005@aliyun.com+86 13808628560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026